FASLG and myeloproliferative disorder: On the contrary, no significant association betwwen FASL-844 polymorphisms and development of leukaemia (Chen et al., 2015), breast cancer (Sun et al., 2004a), and chronic myeloproliferative disorder (Ozdemirkiran et al., 2017) have been reported.